Reviva Pharmaceuticals Holdings Inc (RVPH) Annual Balance Sheets

Annual · GAAP · USD millions
Access RVPH quarterly Balance Sheets →
The data below summarizes Reviva Pharmaceuticals Holdings Inc's balance sheet position from Dec 31 2021 to Dec 31 2025, enabling a period-by-period comparison of financial strength.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent14.44
Cash & Short-term Investments14.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.66
Total Current Assets15.10
Other Assets, Noncurrent0.82
Prepaid Clinical Trial Costs-
Prepaid Clinical Trial Costs Noncurrent0.82
Total Assets15.92
Liabilities
Accounts Payable, Current AC3.01
Employee-related Liabilities, Current AC0.49
Short-term Debt DE10.41
Other Liabilities, Current3.37
Total Current Liabilities7.28
Total Long-term Debt0.00
Derivative Liability, Noncurrent DE0.00
Other liabilities, Noncurrent0.00
Accrued Clinical Expenses2.58
Total Liabilities7.28
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock192.77
Retained Earnings / Accumulated Deficit-184.14
Other Equity0.00
Common Stockholder's Equity8.65
Total Stockholder's Equity8.65
Liabilities & Stockholder's Equity15.92
4 historic quarters locked

Sign in to unlock the full Reviva Pharmaceuticals Holdings Inc balance sheet history.

About Reviva Pharmaceuticals Holdings Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001437749-26-010126

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License